These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 3680887)
1. Long-term oral administration of memory-enhancing doses of tacrine in mice: a study of potential toxicity and side effects. Fitten LJ; Flood JF; Baxter CF; Tachiki KH; Perryman K J Gerontol; 1987 Nov; 42(6):681-5. PubMed ID: 3680887 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of acute bis(7)-tacrine treatment on behavioral functions in 17-day-old and 30-day-old mice, with attention to drug toxicity. Pan SY; Yu ZL; Dong H; Lee NT; Wang H; Fong WF; Han YF; Ko KM Pharmacol Biochem Behav; 2007 Apr; 86(4):778-83. PubMed ID: 17449090 [TBL] [Abstract][Full Text] [Related]
3. Tacrine treatment at high dose suppresses the recognition memory in juvenile and adult mice with attention to hepatotoxicity. Pan SY; Guo BF; Zhang Y; Yu Q; Yu ZL; Dong H; Ye Y; Han YF; Ko KM Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):421-7. PubMed ID: 21232021 [TBL] [Abstract][Full Text] [Related]
4. Oral tacrine administration in middle-aged monkeys: effects on discrimination learning. Fitten LJ; Perryman K; Tachiki K; Kling A Neurobiol Aging; 1988; 9(2):221-4. PubMed ID: 3374739 [TBL] [Abstract][Full Text] [Related]
5. Effects of a memory enhancing peptide on cognitive abilities of brain-lesioned mice: additivity with huperzine A and relative potency to tacrine. Xu Z; Zheng H; Law SL; Dong So D; Han Y; Xue H J Pept Sci; 2006 Jan; 12(1):72-8. PubMed ID: 15942937 [TBL] [Abstract][Full Text] [Related]
6. Effect of acute arecoline, tacrine and arecoline + tacrine post-training administration on retention in old mice. Flood JF; Cherkin A Neurobiol Aging; 1988; 9(1):5-8. PubMed ID: 3380255 [TBL] [Abstract][Full Text] [Related]
7. Effect of acute arecoline, tacrine, and arecoline + tacrine post-training administration on retention in late middle-aged mice. Flood JF J Gerontol; 1988 Mar; 43(2):B54-6. PubMed ID: 3346520 [TBL] [Abstract][Full Text] [Related]
8. Potential neurotoxicity of a novel aminoacridine analogue. Walker TM; Starr B; Dewhurst BB; Atterwill C Hum Exp Toxicol; 1995 Jun; 14(6):469-74. PubMed ID: 8519521 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of acute tacrine treatment on passive-avoidance response, open-field behavior, and toxicity in 17- and 30-day-old mice. Pan SY; Han YF; Yu ZL; Yang R; Dong H; Ko KM Pharmacol Biochem Behav; 2006 Sep; 85(1):50-6. PubMed ID: 16919317 [TBL] [Abstract][Full Text] [Related]
10. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients. Almkvist O; Jelic V; Amberla K; Hellström-Lindahl E; Meurling L; Nordberg A Dement Geriatr Cogn Disord; 2001; 12(1):22-32. PubMed ID: 11125238 [TBL] [Abstract][Full Text] [Related]
11. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study. Gauthier S; Bouchard R; Lamontagne A; Bailey P; Bergman H; Ratner J; Tesfaye Y; Saint-Martin M; Bacher Y; Carrier L N Engl J Med; 1990 May; 322(18):1272-6. PubMed ID: 2183056 [TBL] [Abstract][Full Text] [Related]
12. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. Summers WK; Majovski LV; Marsh GM; Tachiki K; Kling A N Engl J Med; 1986 Nov; 315(20):1241-5. PubMed ID: 2430180 [TBL] [Abstract][Full Text] [Related]
13. The evaluation of nootropic drug effects in aging rats. Benesová O; Tejkalová H; Kristofíková Z; Binková B; Tucek S; Dlohozková N Act Nerv Super (Praha); 1990 Mar; 32(1):53-5. PubMed ID: 1973017 [No Abstract] [Full Text] [Related]
14. Schisandrin B protects against tacrine- and bis(7)-tacrine-induced hepatotoxicity and enhances cognitive function in mice. Pan SY; Han YF; Carlier PR; Pang YP; Mak DH; Lam BY; Ko KM Planta Med; 2002 Mar; 68(3):217-20. PubMed ID: 11914957 [TBL] [Abstract][Full Text] [Related]
15. Quantitative whole-body autoradiographic determination of tacrine tissue distribution in rats following intravenous or oral dose. McNally W; Roth M; Young R; Bockbrader H; Chang T Pharm Res; 1989 Nov; 6(11):924-30. PubMed ID: 2594683 [TBL] [Abstract][Full Text] [Related]
17. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine. Chatellier G; Lacomblez L BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease. Forsyth DR; Wilcock GK; Morgan RA; Truman CA; Ford JM; Roberts CJ Clin Pharmacol Ther; 1989 Dec; 46(6):634-41. PubMed ID: 2598567 [TBL] [Abstract][Full Text] [Related]
19. Genotoxicity of tacrine in primary hepatocytes isolated from B6C3F1 mice and aged ad libitum and calorie restricted Fischer 344 rats. Shaddock JG; Feuers RJ; Chou MW; Swenson DH; Casciano DA Mutat Res; 1995 Aug; 344(1-2):79-88. PubMed ID: 7565897 [TBL] [Abstract][Full Text] [Related]
20. Tacrine in the treatment of Alzheimer's disease. A clinical update and recent pharmacologic studies. Summers WK; Tachiki KH; Kling A Eur Neurol; 1989; 29 Suppl 3():28-32. PubMed ID: 2693104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]